Cochlear Limited (ASX: COH) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Cochlear Limited Chart and Price Data
Fundamentals Data provided by Morningstar.
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Cochlear Limited (ASX: COH)
Latest News
Share Gainers
Why Cochlear, Goodman, Lovisa, & Whispir shares are surging higher
Share Market News
Cochlear (ASX:COH) share price in focus after delivering a solid half year result
Share Market News
5 things to watch on the ASX 200 on Friday
Technology Shares
Here's why the Altium (ASX:ALU) share price could be a buy
Share Market News
Top brokers name 3 ASX shares to buy next week
Growth Shares
5 fantastic ASX shares to buy right now
Share Market News
Leading brokers name 3 ASX shares to sell today
⏸️ ASX Shares
Brokers name 2 ASX blue chips to buy
⏸️ ASX Shares
2 ASX healthcare shares to buy this week
How to invest
How to turn $20,000 into $250,000 in 10 years with ASX shares
⏸️ ASX Shares
2 of the best blue chip ASX shares to buy today
Growth Shares
3 quality SaaS ASX shares to buy
Frequently Asked Questions
-
Yes, Cochlear Ltd has historically paid two fully franked dividends a year.
-
Cochlear Ltd generally pays its dividends in April and October.
-
Cochlear Ltd listed on the ASX on 4 December 1995.
COH ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Cochlear Limited
Cochlear Ltd (ASX: COH) is the world's leading cochlear implant device manufacturer with around half of global market share.
The company was founded in Australia in 1983 to commercialise implants pioneered by Melbourne researcher Dr Graeme Clark, but later became a separate entity.
Developed markets contribute the bulk of Cochlear's group revenue with cochlear implants the standard of care for children with severe to profound hearing loss. The company is also catering for a growing cohort of seniors when standard hearing aid technology loses its effectiveness.
Cochlear's main products include cochlear implants, bone-anchored hearing devices, and associated sound processors. The vast majority of Cochlear's revenue is derived from overseas, with the US and Europe by far the company's two largest markets.
